Results 231 to 240 of about 126,514 (307)

A Doxorubicin‐Loaded Liposomes Baghdadite System for Localized Osteosarcoma Therapy and Bone Regeneration

Advanced NanoBiomed Research, Volume 6, Issue 6, June 2026.
This study presents a multifunctional Baghdadite ceramic implant integrating doxorubicin‐loaded liposomes via ion‐assisted plasma polymer coating for localized osteosarcoma therapy. The platform enables drug retention, sustained release, tumor cell inhibition, osteoconductivity, and antibacterial activity, offering a mechanically robust strategy for ...
Sally Kortam, Zufu Lu, Iman Roohani, Ghazal Shineh, Leila Mamizadeh Janghour, Huu Nguyen Ngoc, Pooria Lesani, Behnam Akhavan, Hala Zreiqat   +8 more
wiley   +1 more source

Statement of Retraction: MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1). [PDF]

Bioengineered
europepmc   +1 more source

[Retracted] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway. [PDF]

Oncol Rep
Shu X, Liu H, Zhen R, Jie Y, Chen L, Qi H, Wang C, Wang R, Chen D, Ran Y.   +9 more
europepmc   +1 more source

A Multiple Imputation Approach to Distinguish Curative From Life‐Prolonging Effects in the Presence of Missing Covariates

Biometrical Journal, Volume 68, Issue 3, June 2026.
ABSTRACT Medical advances have increased cancer survival rates and the possibility of finding a cure. Hence, it is crucial to evaluate the impact of treatments both in terms of cure and prolongation of survival. To achieve this, we may use a Cox proportional hazards cure model.
Marta Cipriani, Marta Fiocco, Marco Alfò, Maria Quelhas, Eni Musta   +4 more
wiley   +1 more source

Macrophage plasticity in the osteosarcoma tumor microenvironment: opportunities and challenges for immunotherapy. [PDF]

J Cancer Res Clin Oncol
Li H, Liu C, Zhang B, Zhang Y, Liu Y.
europepmc   +1 more source

Malignant Ovarian Germ Cell Tumor—Survival and Reproductive Outcomes and Patterns of Relapse

Cancer Medicine, Volume 15, Issue 6, June 2026.
BLURB FOR ETOC: Patients presenting with advanced MOGCT can be offered fertility‐sparing surgery after neoadjuvant chemotherapy with no detriment in oncological outcome. ABSTRACT Background Malignant ovarian germ cell tumors [MOGCT] are rare cancers affecting young women and often present in advanced stages.
Sayak Dey, Srikant Anne, Sushmita Rath, Ravindra Nandhana, Seema Gulia, Biswajit Dash, Santosh Menon, Bharat Rekhi, Akshay Baheti, Nilesh Sable, Palak Popat, Sandeep Tandon, Kinjalka Ghosh, Lavanya Gurram, Sarika Shivram Parab, Apenla N. Logkumer, Sunita Jhadhav, Supriya Chopra, Shylasree T. Surappa, Vandana Bansal, Geeta Balsarkar, Kedar Deodhar, Amita Maheshwari, Jaya Ghosh, Sudeep Gupta   +24 more
wiley   +1 more source

Age-related real-world treatment patterns and outcomes of localised, high-grade osteosarcoma. [PDF]

J Bone Oncol
Fujiwara T, Iwata S, Nagano A, Tsuchihashi K, Kawai A, Ozaki T.   +5 more
europepmc   +1 more source

Lactylation-driven metabolic reprogramming promotes osteosarcoma malignancy via HDGF-mediated proliferation and immune modulation. [PDF]

Front Immunol
Hu S, Wu L, Wang J, Dai F.
europepmc   +1 more source

Methotrexate Toxicity in a Patient With Renal Failure Despite a Normal Methotrexate Concentration: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Methotrexate (MTX) is a folate antagonist widely used as a disease‐modifying antirheumatic drug (DMARD) in rheumatoid arthritis (RA), as well as in several malignancies and autoimmune disorders. Although low‐dose MTX (5–20 mg/week) is generally considered safe, it has a narrow therapeutic index, and toxicity can occur even at therapeutic doses,
Fatemeh Afra, Mahshad Ghoddusi, Mahsa Mottahedi, Maryam Albaji, Samira Kafan, Roya Saedpanah, Amir Shokri, Elham Nazar   +7 more
wiley   +1 more source

Effect of Osteoblast-Derived Extracellular Vesicles on Osteosarcoma Cells' Transcriptional Profile: Role of Shuttled miRNAs. [PDF]

Biomedicines
Giacchi L, Ucci A, Zelli V, Compagnoni C, Pucci E, Tessitore A, Ponzetti M, Rucci N.   +7 more
europepmc   +1 more source